'Solve.Care is a healthcare IT company that builds blockchain platforms which the team believes may improve the way healthcare is delivered and managed. The Solve.Care platform reportedly uses blockchain technology as the underlying distributed ledger for coordinating care, benefits and payments between all parties in the chain of healthcare: patients, doctors, pharmacies, laboratories, employers, insurers, and others. SOLVE tokens may be used to secure efficient and transparent healthcare administration around the world. The token supply is fixed and the price variable, as determined by market supply and demand. SOLVE token runs natively on the Ethereum blockchain and is designed to follow the ERC20 token standard. SOLVE utility tokens are the currency used for transactions on the platform. According to the foundation, they can be utilized to pay for Care Administration Network fees, establish Care.Wallets, purchase Care.Cards, and participate in Care.Marketplace services as well as pay for associated integration fees. In addition, SOLVE is reportedly used for the emission of Care.Coins and payments requiring Care.Coins.'
BCAChain Using self-optimized POBC (goodwill certification) as the underlying consensus mechanism, and introducing the real world credit system to provide better operation and support for anonymous block chain network. BCAChain Focus on the new retail industry with rich landing scenarios, aiming at creating a supply chain traceability, quantifiable credit, transparent data, consumer shopping, membership services, precision marketing, centralized procurement scenarios in one, forming online e-commerce transactions, offline shopping experience, and building a new retail public chain ecology with multi-participation and multi-benefit. On November 8, 2018, BCAChain Foundation officially joined China Cloud System Industry Innovation Strategic Alliance as a governing unit. At present, BCAChain has completed the release of open source code at the bottom of block chain, wallet and DAPP application, and is expected to be on the main line in the second half of 2019.